Keywords: ligand, sells, marathon, assets, million, pharmaceuticals, says
Ligand sells Marathon assets for $10 million
Article | 11 January 2000
Ligand Pharmaceuticals says it has sold the assets of its contractmanufacturing subsidiary Marathon Biopharmaceuticals to CoPharma for $10 million in cash. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
